Access our research outputs, including our publication and soundbites. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters October 2022: Research published in The Lancet looks at who is at higher risk of serious illness following an Omicron infection, after a third or booster dose of COVID-19 vaccine. Listen to our soundbites Short series of one-minute sound bite clips covering different aspects of the Vaccine Breakthroughs Project's research, from research highlights to real world implications. Created with the input and voices of our Patient and Public volunteer members. To hear more about COVID-19 research, including National Core Studies: Immunity projects, visit the COVID Vaccine Research Hub.To learn more about relevant previous research:Visit the EAVE II Publications pageVisit the DaC-VaP research siteVisit the DaC-VaP-2 research site This article was published on 2024-09-24